Association of rs1042522 Polymorphism with Increased Risk of Prostate Adenocarcinoma in the Pakistani Population and its HuGE Review |
Khan, Mohammad Haroon
(Department of Bioinformatics, Mohammad Ali Jinnah University)
Rashid, Hamid (Department of Bioinformatics, Mohammad Ali Jinnah University) Mansoor, Qaiser (Institute of Biomedical and Genetic Engineering) Hameed, Abdul (Institute of Biomedical and Genetic Engineering) Ismail, Muhammad (Institute of Biomedical and Genetic Engineering) |
1 | Leiros GJ, Galliano SR, Sember ME (2005). Kahn T, Schwarz E, Eiguchi K. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol, 5, 15. DOI |
2 | Khoo KH, Andreeva A, Fersht AR (2009). Adaptive evolution of p53 thermodynamic stability. J Mol Biol, 393, 161-75. DOI ScienceOn |
3 | Kiraga J, Mackiewicz P, Mackiewicz D, et al (2007). The relationships between the isoelectric point and: length of proteins, taxonomy and ecology of organisms. BMC Genomics, 8, 163. DOI ScienceOn |
4 | Levine AJ, Oren M (2009). The first 30 years of p53: growing ever more complex. Nat Rev Cancer, 9, 749-58. DOI ScienceOn |
5 | Murphy ME (2006). Polymorphic variants in the p53 pathway. Cell Death Differ, 13, 916-20. DOI ScienceOn |
6 | Nandi S, Mehra N, Lynn AM, Bhattacharya A (2005). Comparison of theoretical proteomes: identification of COGs with conserved and variable pI within the multimodal pI distribution. BMC Genomics, 6, 116. DOI ScienceOn |
7 | Ng PC, Henikoff S (2003). SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res, 31, 3812-4. DOI ScienceOn |
8 | Quinones LA, Irarrazabal CE, Rojas CR, et al (2006). Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J Androl, 8, 349-55. DOI ScienceOn |
9 | Reinhardt HC, Schumacher B (2012). The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet, 28, 128-36. DOI ScienceOn |
10 | Eswar N, Marti-Renom Ma, Webb B, et al (2006). Comparative protein structure modeling with MODELLER. Curr Protoc Protein Sci, ps0209s50. |
11 | Choi Y, Sims GE, Murphy S, Miller JR, Chan AP (2012). Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLoS ONE, 7, 46688. DOI |
12 | Doosti A, Dehkordi PG (2011). The p53 codon 72 polymorphism and association to prostate cancer in Iranian patients. A J Biotechnol, 10, 12821-5. DOI |
13 | Dumont P, Leu JI, Della PA III, George DL, Murphy M (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 33, 357-65. DOI ScienceOn |
14 | Hirata H, Hinoda Y, Kikuno N, et al (2007). CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res, 13, 5056-62. DOI ScienceOn |
15 | Hu ZH, Lin YW, Xu X, et al (2013). Genetic polymorphisms of glutathione S-transferase M1 and prostate cancer risk in Asians: a meta-analysis of 18 studies. Asian Pac J Cancer Prev, 14, 393-8. 과학기술학회마을 DOI ScienceOn |
16 | Huang SP, Wu WJ, Chang WS, et al (2004). p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Cancer Epidemiol Biomarkers Prev, 13, 2217-24. |
17 | Adzhubei IA, Schmidt S, Peshkin L, et al (2010). A method and server for predicting damaging missense mutations. Nat Methods, 7, 248-9. DOI ScienceOn |
18 | Khaldi N, Shields DC (2011). Shift in the isoelectric-point of milk proteins as a consequence of adaptive divergence between the milks of mammalian species. Biol Direct, 6, 40. DOI |
19 | Bensaad K, Tsuruta A, Selak MA, et al (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 126, 107-20. DOI ScienceOn |
20 | Acikgoz A, Ergor G (2013). Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey. Asian Pac J Cancer Prev, 14, 1737-42. 과학기술학회마을 DOI ScienceOn |
21 | Aydin Z, Singh A, Bilmes J, Noble WS (2011). Learning sparse models for a dynamic bayesian network classifier of protein secondary structure. BMC Bioinformatics, 12, 154. DOI ScienceOn |
22 | Berger MF, Lawrence MS, Demichelis F, et al (2011). The genomic complexity of primary human prostate cancer. Nature, 470, 214-20. DOI ScienceOn |
23 | Boyd LK, Mao X, Lu YJ (2012). The complexity of prostate cancer: genomic alterations and heterogeneity. Nat Rev Urol, 9, 652-64. DOI ScienceOn |
24 | Capriotti E, Marti-Renom MA (2010). Quantifying the relationship between sequence and three-dimensional structure conservation in RNA. BMC Bioinformatics, 11, 322. DOI ScienceOn |
25 | Cheng J, Randall AZ, Sweredoski MJ, Baldi P (2005). SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res, 33, 72-6. |
26 | Wang NN, Xu Y, Yang K, et al (2014). Susceptibility loci associations with prostate cancer risk in northern Chinese men. Asian Pac J Cancer Prev, 14, 3075-8. 과학기술학회마을 DOI ScienceOn |
27 | Wu HC, Chang CH, Chen HY, et al (2004). p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol Int, 73, 41-6. DOI ScienceOn |
28 | Zhao CX, Liu M, Wang JY, et al (2014). Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men. Asian Pac J Cancer Prev, 14, 6733-8. 과학기술학회마을 DOI ScienceOn |
29 | Waheed R, Khan MH, Bano R, Rashid H (2012). Sequence and structure based assessment of nonsynonymous SNPs in hypertrichosis universalis. Bioinformation, 8, 316-8. DOI ScienceOn |
30 | Whibley C, Pharoah PD, Hollstein M (2009). p53 polymorphisms: Cancer implications. Nat Rev Cancer, 9, 95-07. DOI ScienceOn |
31 | Xu B, Xu Z, Cheng G, et al (2010). Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese. Cancer Genet Cytogenet, 202, 76-81. DOI ScienceOn |
32 | Xu CT, Zheng F, Dai X, et al (2012). Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 4305-9. 과학기술학회마을 DOI ScienceOn |
33 | Xu D, Zhang Y (2011). Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophysical Journal, 101, 2525-34. DOI ScienceOn |
34 | Reva B, Antipin Y, Sander C (2011). Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res, 39, 118. |
35 | Zhang H, Xu Y, Zhang Z, Liu R, Ma B (2012). Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol, 13, 14. DOI ScienceOn |
36 | Zhang LL, Sun L, Zhu XQ, et al (2014). rs10505474 and rs7837328 at 8q24 cumulatively confer risk of prostate cancer in northern Han Chinese. Asian Pac J Cancer Prev, 15, 3129-32. 과학기술학회마을 DOI ScienceOn |
37 | Rivlin N, Brosh R, Oren M, Rotter V (2011). Mutations in the p53 Tumor Suppressor Gene: important milestones at the various Steps of tumorigenesis. Genes Cancer, 2, 466-74. DOI ScienceOn |
38 | Ricks-Santi L, Mason T, Apprey V, et al (2010). p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate, 70, 1739-45. |
39 | Ricks-Santi LJ, Apprey V, Mason T, et al (2012). Identification of genetic risk associated with prostate cancer using ancestry informative markers. Prostate Cancer Prostatic Dis, 15, 359-64. DOI ScienceOn |
40 | Rogler A, Rogenhofer M, Borchardt A, et al (2011). P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype. Pathobiol, 78, 193-200. DOI ScienceOn |
41 | Shi H, Tan SJ, Zhong H, et al (2009). Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet, 84, 534-41. DOI ScienceOn |
42 | Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011. CA Cancer J Clin, 61, 212-36. DOI |
43 | Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993). PROCHECK-a program to check the stereochemical quality of protein structures. J App Cryst, 26, 283-91. DOI ScienceOn |
44 | Suzuki K, Matsui H, Ohtake N, et al (2003). A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J Biomed Sci, 10, 430-5. DOI |
45 | Thut CJ, Chen JL, Klemm R, Tjian R (1995). p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science, 267, 100-4. DOI ScienceOn |
46 | Henner WD, Evans AJ, Hough KM, et al (2001). Association of codon 72 polymorphism of p53 with lower prostate cancer risk. Prostate, 49, 263-6. DOI ScienceOn |
47 | Wang Z, Eickholt J, Cheng J (2011). APOLLO: A quality assessment service for single and multiple protein models. Bioinformatics, 27, 1715-6. DOI ScienceOn |
48 | Tafrihi M, Toosi S, Minaei T, et al (2014). Anticancer properties of Teucrium persicum in PC-3 prostate cancer cells. Asian Pac J Cancer Prev, 15, 785-91. 과학기술학회마을 DOI ScienceOn |
49 | Karimpur-Zahmatkesh A, Farzaneh F, Pouresmaeili F, Hosseini J, Azarghashb E, Yaghoobi M (2013). A2 allele polymorphism of the CYP17 gene and prostate cancer risk in an iranian population. Asian Pac J Cancer Prev, 14, 1049-52. 과학기술학회마을 DOI ScienceOn |